The Effectiveness and Safety of Electromagnetic Navigation Real-time Guided Percutaneous Lung Biopsy
NCT ID: NCT05799014
Last Updated: 2023-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2023-03-30
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will undergo CT-guided percutaneous lung biopsy or percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application of Three-Dimensionally Printed Navigational Template in Lung Biopsy
NCT04775901
ENB Vs. Conventional Bronchoscopy With Fluoroscopy for Safe and Effective Biopsy of Pulmonary Lesions
NCT04447482
The Effectiveness and Safety of Ultrasound Elastography Guided Pleural Biopsy in the Differential Diagnosis of Benign and Malignant Pleural Effusion
NCT05781659
CT-guided Needle Guidance Using Stereotaxic Unit, Navigation Versus Conventional Biopsy Technique for the Percutaneous Pulmonary Nodule Biopsy
NCT03321994
ENB-GS-TBLB for the Diagnosis of PPLs
NCT02207478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Traditional CT-guided percutaneous lung biopsy group
CT-guided percutaneous lung biopsy
The participants would undergo CT-guided percutaneous lung biopsy.
Percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology group
Percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology
The participants would undergo percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CT-guided percutaneous lung biopsy
The participants would undergo CT-guided percutaneous lung biopsy.
Percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology
The participants would undergo percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Imaging examination showed peripheral lung lesions
* Selected patients need to complete routine preoperative examinations such as blood routine examination, coagulation function, electrocardiogram, chest CT, etc
* There is no contraindication for puncture biopsy
* Good compliance, able to cooperate with research and observation
* Fully informed of the purpose and method of the study, agreed to participate in the study, and signed the informed consent form
Exclusion Criteria
* The patient is allergic to lidocaine and midazolam
* The site to be biopsied has a high risk of bleeding such as bronchial artery penetration or suspected lung metastasis of renal cancer
* Unstable angina pectoris, congestive heart failure, severe bronchial asthma
* The patient did not agree to participate in the study
* Participation in other studies within three months without withdrawal or termination will affect the observation of this study
* The researcher believes that there is any person who is not suitable for the selection
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China-Japan Friendship Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gang Hou
Principal Investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-NHLHCRF-LX-01-0201-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.